Sign up to save your podcasts
Or
Share Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.4
6969 ratings
Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.
CME information and select publications here.
More shows like Hematologic Oncology Update
View all
JAMA Editors' Summary
129 Listeners
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
31 Listeners
Prostate Cancer Update
15 Listeners
Breast Cancer Update
63 Listeners
Gynecologic Oncology Update
11 Listeners
Dermatologic Oncology Update
0 Listeners
NEJM This Week
316 Listeners
Research To Practice | Oncology Videos
114 Listeners
The Hematologist
26 Listeners
JAMA Clinical Reviews
487 Listeners
Annals On Call Podcast
184 Listeners
Blood Podcast
51 Listeners
Oncology Today with Dr Neil Love
53 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
166 Listeners
Blood Cancer Talks
48 Listeners